Introduction 28
After biosynthesis in the endoplasmic reticulum (ER), proteins are transported to their destination via 29 the secretory pathway. Transport processes are highly flexible and adapt to new requirements for 30 instance during differentiation or after activation (Farhan and Rabouille, 2011; McCaughey and 31 Stephens, 2018). This adaptation is achieved either by differential gene expression (Coutinho et phosphatases (Farhan et al., 2010) . Alternative splicing has been shown to react highly dynamic to 35 various external stimuli (Heyd and Lynch, 2011; Preußner et al., 2017 ) and would thus be perfectly 36 suited to control protein secretion in response to changing cellular environments. Indeed, we have 37 previously described how AS of SEC16A exon 29 increases the efficiency of the early secretory pathway 38 (Wilhelmi et al., 2016 ) but this remains one isolated example. Here, we globally identify AS events that 39 modulate the secretory pathway in a tissue-specific and activation-and differentiation-dependent 40 manner. 41
Results and discussion 42
To identify regulators of the secretory pathway, several RNAi screens have been performed (Farhan, 43 2015) . One of these screens used the VSVG reporter to monitor protein transport upon knock-down 44 (KD) of 22,000 human genes (Simpson et al., 2012) . In this screen, four RNA-binding proteins (RBPs) 45 that regulate AS and whose KD led to a strong inhibition of secretion were identified (Figure 1 -Source 46 Data 1): HNRNPA1, PTBP1, RBM27 and SRSF1 ( Figure 1A ). As these RBPs have no known direct function 47 in protein secretion, we considered an indirect effect, through controlling AS of components of the 48 secretory pathway, which then changes cargo flux ( Figure 1B) . We therefore used KD RNA-Seq datasets 49 of these RBPs to determine their splicing targets. We propose that the impact of these RBPs on the 50 secretory pathway is mediated by a network of common AS events and thus generated an overlap of 51 splicing targets that were differential in the single KDs. We defined those that were regulated by at 52 least three of the four RBPs as potential secretion modulators, henceforth called secretion events 53 3 ( Figure 1C ). Meta-analysis of these events, which are mostly cassette exons, indicates that they have 54 a modulatory effect on protein function instead of regulating total gene expression, as they lie almost 55 exclusively within the coding sequence and consist of less NMD (nonsense-mediated decay)-inducing 56 exons when compared to the skipped exons that are regulated by any of these RBPs (RBP background, 57
Figure 1 -figure supplement 1). When performing gene ontology (GO) analysis, only three terms for 58 biological processes were found significantly enriched, all of which fit the hypothesis that the secretion 59 events play a role in membrane trafficking ( Figure 1D ). We then grouped the AS-controlled proteins by 60 function ( Figure 1E ). As expected, a large cluster is directly connected to the secretory pathway or to 61 cytoskeletal organizers that can provide scaffolding functions for vesicle transport. Additionally, we 62 find phosphoinositide homeostasis and ARF signalling, which are known to regulate vesicular 63 trafficking (Ooms et al., 2009 ) and proteins involved in kinase and phosphatase signalling, which can 64 post-translationally control trafficking proteins (Farhan et al., 2010) . Apart from these targets, there 65 are several groups that may have an indirect effect on secretion: transcriptional, post-transcriptional 66 and translational modulators can change gene and protein expression of various targets, which can be 67 further controlled by degradation pathways. Mitochondrial proteins could impact on mitochondria-68 related traffic. Finally, there are several chaperones, a group of proteins which have been shown to 69 influence protein secretion as well (Roth et al., 2012) . Closer inspection of the proteins known to be 70 direct part of the trafficking machinery revealed that they are localized in all compartments along the 71 secretory pathway ( Figure 1E) . 72
To validate the functionality of the secretion events we employed the RUSH system (Boncompain et 73 al., 2012) in which a GFP-GPI reporter is transported from the ER to the PM after addition of biotin. 74
Upon arrival of the reporter at the PM, GFP will be located on the extracellular side and can be 75 quantified by staining against GFP without permeabilizing the cell (Figure 2A) . A time course 76 experiment in HEK293T cells and the quantification of antibody-stained (PM-localized) GFP per cell is 77 shown in Figure 2B . To verify that expression levels of HNRNPA1, PTBP1, RBM27 and SRSF1 had an 78 effect on protein transport in our assay, we performed KDs of these proteins and of two further RBPs 79 Neumann et al.
4
(MBNL3, SRSF6) as a control ( Figure 2C ). The RUSH assay was subsequently performed with GFP 80 staining 1 h after biotin addition. While we did not observe a significant difference between control 81 and either the MBNL3, SRSF6 or HNRNPA1 KDs, cells treated with siPTBP1, siRBM27 or siSRSF1 showed 82 a substantial and highly significant decrease in GFP surface staining ( Figure 2D, E) . The lack of an 83 influence of the HNRNPA1 KD (Simpson et al., 2012) may be due to the use of a different reporter in 84 our study, which could point to a role in cargo selectivity. However, we also notice that HNRNPA1 has 85 the least common splicing targets among the four RBPs, as the largest overlap in our analysis are the 86 targets controlled by PTBP1, RBM27 and SRSF1 ( Figure 1C ). For further validations, we therefore 87 focussed on events that were controlled by these three RBPs. 88
To validate the influence of individual splicing events on secretion, we selected four targets that are 89 directly involved in different parts of the secretory pathway ( Figure 1E To independently validate the observed effect, we used CRISPR/Cas9 to generate isoform-specific 101 knock-outs (KOs). We selected the alternative microexon 19 in OCRL, as it stands out both because the 102 MO-induced splicing change from about 25% inclusion to complete exclusion led to a drastic transport 103 defect and as this is achieved by exclusion of only 8 amino acids. We generated four independent OCRL 104 exon 19 KO cell lines and validated them both on genomic and transcriptomic level (Figure 3 -figuresupplement 1A, Figure 3D ). Cell lines showed expression of only the exclusion isoform with the overall 106 expression level remaining largely unchanged (Figure 3 -figure supplement 1B) . We then performed 107 the RUSH assay and again observed a highly significant reduction of surface-GFP for all clones in the 108 same range as for the OCRL exon 19 MO-treated cells, further validating the MO approach ( Figure 3E) . 109
In addition, when expressing OCRL full-length protein for a short period (Figure 3 -figure supplement  110 1C) in the KO cells, the defect in protein secretion was partially rescued (Figure 3F ), while there was 111 no effect observed in wild-type cells (Figure 3 -figure supplement 1D ). These data together validate 112 our bioinformatics approach, as all tested splicing events indeed control protein transport efficiency. 113
This strongly increases the confidence in our group of secretion events, thereby adding a new 114 regulatory layer to the secretory pathway and substantially increasing the number of alternative 115 isoforms with known cellular functionality. 116
To address the physiological significance of the connection between AS and protein transport, we 117 investigated whether the secretion events act in a tissue-, differentiation-or activation-dependent 118 manner. To this end, we initially used RNA-Seq data from various human organs to calculate inclusion 119 levels for the secretion and RBP background events. We indeed observed a tissue-specific usage for a 120 larger proportion of the secretion events in comparison to the RBP background ( Figure 4A, Figure 4 -121 figure supplement 1A). When calculating measures of variability between tissues, more secretion 122 events were found differential in any two-way comparison ( Figure 4B ) and the strongest PSI (percent 123 spliced in) difference of an event between tissue was larger ( Figure 4C ). This strongly points to a global 124 role of AS in adapting the secretory pathway to tissue-specific requirements. Next, we turned to two 125 cellular systems where cells with basal secretory requirements differentiate into a cell type with higher 126 secretory load ( Figure 4D ): T-cell activation and differentiation of pre-adipocytes into adipocytes. We 127 analysed differential AS using RNA-Seq datasets from primary human CD4 + T-cells and human SGBS 128 adipocytes pre-and post-differentiation and found significant overlaps with the secretion events in 129 both sets ( Figure 4E, F We observed that while the T-cell overlap events are found in all parts of the secretory pathway, the 133 adipocyte overlap events mainly locate in post-Golgi compartments, which is also reflected in GO term 134 analysis (Figure 4 -figure supplement 1D) . Additionally, we find that components of the COPII 135 machinery are upregulated during adipocyte differentiation but not during T-cell activation ( Figure 4G , 136 machinery, which is achieved by AS. These data together strongly argue for a global role of AS in 149 controlling the efficiency of the secretory pathway in a tissue-specific manner, as well as in dynamic 150 settings such as differentiation and activation (Figure 4 -figure supplement 1E) . 151
In summary, we combine data from a genome-wide screen for modulators of protein secretion with 152 knock-down RNA-Seq datasets to discover over 200 AS events that, based on our validations using the 153 RUSH-system, are high-confidence secretion regulators. Our analysis shows that AS is involved in 154 regulating all stages of the secretory pathway ( Figure 4H ). We furthermore show that secretion-155 regulating AS events are used in diverse biological contexts to adapt the secretory pathway to tissue-156 specific or differentiation-and activation-dependent requirements ( Figure 4H, Figure 4 Gene expression analysis was performed using DESeq2 (Anders et al., 2012) . Further analyses were 183 performed using custom Python scripts. GO term analyses were performed using the PANTHER 184 classification system version 13.1 (https://pantherdb.org) (Mi et al., 2013) . Network maps were 185 generated using Cytoscape version 3.6.1 (Montojo et al., 2010) . 
RNA extraction, RT-PCR, RT-qPCR and PCR 211
RNAs from primary human T-cells were prepared as described (Michel et al., 2014) . RNA extraction, 212 radioactive RT-PCR and Phosphor imager quantification were performed as previously 213 described (Wilhelmi et al., 2016) . RNA was extracted using RNATri (Bio&Sell, Feucht, Germany). For 214 reverse transcription, 1 µg RNA was used with a gene-specific reverse primer. Low-cycle PCRs were 215 performed with a radioactively-labelled forward primer and products were separated by denaturing 216 PAGE. Imaging was done using a Phosphoimager and gels quantified using ImageQuantTL version 8.1 217 (GE, Boston, Massachusetts, US). qPCRs were performed in technical duplicates in a 96-well format 218 
Microscopy and analysis 242
Fluorescence microscopy was performed on a Leica SP8 confocal microscope. Image analysis was 243 performed using custom Python scripts. To calculate percent stained GFP, single cells were initially 244 defined by user input. Pixels were defined GFP-positive (green value) or GFP staining-positive (red 245 value) if the respective intensity value was above a certain threshold (75 for green, 65 for red 246 fluorescence). %GFP staining was calculated as the number of double-positive pixels divided by the 247 number of green-positive pixels multiplied by 100. 248
Immunoblotting 249
Whole cell lysates were prepared in RIPA buffer (10 mM TrisHCL pH 8.0, 2 mM EDTA, 100 mM NaCl, 250 1% NP-40, 5 mg/mL sodium deoxycholate, with protease inhibitors). SDS-PAGE and western blotting 251 followed standard procedures. Antibodies used: mouse monoclonal anti-HA-probe (F-7, 1:1000, Santa 252
Cruz Biotechnology, Dallas, Texas, US), mouse anti-Gapdh (1:1000, antibodies online, Aachen, 253
Germany) and horse anti-mouse IgG, HRP-linked (1:5000, Cell Signaling, Danvers, Massachusetts, US) 254
Statistics 255
If not mentioned otherwise, either one-sample or unpaired T tests were used to calculate p values. 
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